About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. The company, headquartered in the Netherlands, is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips’ health technology portfolio generated 2015 sales of EUR 16.8 billion and employs approximately 69,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.
About the Future Health Index
Philips undertook original research to understand the perception towards connected care and the role it plays in the future of healthcare. The study, which will be run annually, included both quantitative surveys and qualitative in-depth interviews. These were conducted from February-April, 2016 in 13 countries. In partnership with an independent global market research firm, a survey was fielded from February 24, 2016 to April 8, 2016 in Australia, Brazil, China, France, Germany, Japan, The Netherlands, Singapore, South Africa, Sweden, UAE, U.K. and U.S. in their native language. A combination of online, face-to-face (computer-assisted) and phone (computer-assisted) interviewing was used to reach a total sample of:
- 2,659 healthcare professionals (those who work in healthcare as a doctor, surgeon, nurse practitioner, registered nurse, licensed practical nurse or nurse across a variety of specializations)
- 25,355 adult patients (those 18 years old or older who have visited a healthcare professional in the last three months)
- About 200 healthcare professionals and 2,000 patients were surveyed in each country (with the exception of UAE which was 1,000).